The study’s findings, which were published in the Infection and Immunity Journal, notes that exposing chlamydia to the gut first was a unique approach to preventing the infection. In most cases, the first exposure of chlamydia is seen in the genital tract. When that happens, the disease will spread to the gut, and the body responds in a way that causes the disease to spread further.
However, according to University of Texas Health Science Center in San Antonio Professor Guangming Zhong, exposing chlamydia first to the gut means there could be a vaccine for the disease.
Human exposure to the disease is not predictable, as it can come from an infected partner or through contact with a contaminated material. Researchers used mice to control the way and to look at the transmission of chlamydia. What they found was that if the gut was the first area to be exposed, the infection became benign. However, when the genital tract is infected first, the disease spreads.
Zhong and his team looked at developing an oral vaccine using the Chlamydia trachomatis bacteria. He said people use probiotics to protect their GI health, and chlamydia may become a probiotic. Once the bacteria is in the GI tract, they don’t go anywhere else.
The CDC said chlamydia infections are common in young people, with 1 and 20 sexually active women 14 to 24 years old already exposed to the disease.
Written by Mark Riegel, MD
Here’s what we've been up to recently.
With many cases of Human Immunodeficiency Virus (HIV) around the world, there are many people around the world who have shared their experiences and testimonials as to how their lives changed when they were diagnosed with HIV. If you are curious as to how HIV can affect the life of a person, we’ve listed down below facts about living with HIV or AIDS.
Evofem Bio has launched its Phase 2b/3 clinical trial Amprevence and is accepting enrollees to see how its non-hormonal, on-demand and surfactant-free drug Amphora helps in the prevention of female gonorrhea and urogenital chlamydia.